Exclusive Interview with Cellibre Founder and CEO Ben Chiarelli Cannabinoid biosynthesis is an emerging technology that holds the promise of producing THC, CBD, and other cannabinoids at a fraction...

Canadian investment bank AltaCorp Capital has published a research report explaining options for producing cannabinoids from sources beyond cannabis. Analyst and Managing Director David Kideckel, PhD,  explained in “Synthetically-Derived...